Photoactivated hydride therapy under hypoxia beyond ROS

Xia Wang,Yijian Gao,Ting Wang,Zhaobin Wang,He Hang,Shengliang Li,Fude Feng
DOI: https://doi.org/10.1039/d4sc06576j
IF: 8.4
2024-11-13
Chemical Science
Abstract:As compared to oxidative phototherapy, studies on reactive reductive species-participating photodynamic therapy (PDT) are rare. Porphyrins are typical photosensitizers restricted with oxygen level, but efficacy and selectivity are always uncompatible in PDT. Herein, we reported that phlorins are ideal hydride (H – ) donors and explored water-soluble triphenylphosphonium-modified zinc-coordinated porphyrin ( mito ZnPor) for in situ photogeneration of zinc-cored phlorin ( mito ZnPhl). Driven by 1,4-dihydronicotinamide adenine dinucleotide (NADH), the mito ZnPor/ mito ZnPhl couple can reduce electron acceptors like iron heme and ubiquinone that play key roles in mitochondrial electron transportation chain (Mito-ETC). Under hypoxia, mito ZnPor showed excellent cancer-selectivity and highly efficient in vitro PDT effect with IC 50 at nanomolar levels and potent tumor growth inhibition in a 4T1 tumor-xenografted mouse model with good biosafety, which underlines great potentials of Mito-ETC targeted non-classical PDT via a H – -transfer mechanism beyond reactive oxygen species (ROS) in precision cancer phototherapy using NADH as a biomarker and original electron donor.
chemistry, multidisciplinary
What problem does this paper attempt to address?